| Schedule of Net Income Per Share, Basic and Diluted |
The following table sets forth the computations of net income per share for the periods listed: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | Basic net income per share | | | | | | | | | | Numerator: | | | | | | | | | | Net income | | $ | 33,220 | | | $ | 15,048 | | | $ | 89,717 | | | $ | 31,565 | | | Denominator: | | | | | | | | | | Weighted-average common shares outstanding, basic | | 62,153 | | | 62,458 | | | 62,325 | | | 62,015 | | | Net income per common share, basic | | $ | 0.53 | | | $ | 0.24 | | | $ | 1.44 | | | $ | 0.51 | | | | | | | | | | | | Diluted net income per share | | | | | | | | | | Numerator: | | | | | | | | | | Net income | | $ | 33,220 | | | $ | 15,048 | | | $ | 89,717 | | | $ | 31,565 | | Interest expense, net of tax(1) | | — | | | 845 | | | 1,184 | | | — | | | Adjusted net income used in diluted computations | | $ | 33,220 | | | $ | 15,893 | | | $ | 90,901 | | | $ | 31,565 | | | Denominator: | | | | | | | | | | Weighted-average common shares outstanding, basic | | 62,153 | | | 62,458 | | | 62,325 | | | 62,015 | | | Effect of potentially dilutive shares: | | | | | | | | | | Stock options, restricted stock units, market stock units and performance stock units | | 1,368 | | | 2,600 | | | 1,483 | | | 3,056 | | | Shares issuable pursuant to the ESPP | | 8 | | | 7 | | | 10 | | | 5 | | Shares related to convertible notes(2) | | — | | | 4,793 | | | 1,872 | | | — | | | Weighted-average common shares outstanding, diluted | | 63,529 | | | 69,858 | | | 65,690 | | | 65,076 | | | Net income per common share, diluted | | $ | 0.52 | | | $ | 0.23 | | | $ | 1.38 | | | $ | 0.49 | |
(1) Interest expense has been tax effected using the combined federal and blended state rate of 24.9%. (2) The convertible senior notes issued by the Company could have been converted into the Company’s common stock, subject to certain contingencies. The 2026 convertible notes were settled during the three months ended June 30, 2026 and are no longer outstanding. See Note 9—Debt for additional information. The if-converted method is used to calculate the dilutive effect of our convertible notes on diluted net income per common share.
|
| Schedule of Antidilutive Securities Excluded from Computation of Net Income Per Share |
The following table sets forth the anti-dilutive common share equivalents for the periods listed: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | Stock options, restricted stock units, market stock units and performance stock units | | 609 | | 127 | | 502 | | 104 | | | | | | | | | | | Shares related to convertible notes | | — | | — | | — | | 4,793 | Anti-dilutive shares excluded from diluted net income per common share | | 609 | | | 127 | | | 502 | | | 4,897 | |
|